Last reviewed · How we verify
standard chemotherapy medicine combined with Chinese herbs
standard chemotherapy medicine combined with Chinese herbs is a Small molecule drug developed by First Affiliated Hospital, Sun Yat-Sen University. It is currently in Phase 1 development.
At a glance
| Generic name | standard chemotherapy medicine combined with Chinese herbs |
|---|---|
| Sponsor | First Affiliated Hospital, Sun Yat-Sen University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- standard chemotherapy medicine combined with Chinese herbs CI brief — competitive landscape report
- standard chemotherapy medicine combined with Chinese herbs updates RSS · CI watch RSS
- First Affiliated Hospital, Sun Yat-Sen University portfolio CI
Frequently asked questions about standard chemotherapy medicine combined with Chinese herbs
What is standard chemotherapy medicine combined with Chinese herbs?
standard chemotherapy medicine combined with Chinese herbs is a Small molecule drug developed by First Affiliated Hospital, Sun Yat-Sen University.
Who makes standard chemotherapy medicine combined with Chinese herbs?
standard chemotherapy medicine combined with Chinese herbs is developed by First Affiliated Hospital, Sun Yat-Sen University (see full First Affiliated Hospital, Sun Yat-Sen University pipeline at /company/first-affiliated-hospital-sun-yat-sen-university).
What development phase is standard chemotherapy medicine combined with Chinese herbs in?
standard chemotherapy medicine combined with Chinese herbs is in Phase 1.